Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
U.S. · WORLD
March 11, 20213 min read605 words
Published: March 11, 2021  |  3 min read605 words
By , (Reuters) - Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.There were n...
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-trusted
100%
critic score
14 reviews
img-trusted
80%
public score
74 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.